ALS Ltd delivers $3 billion revenue in FY25, unveils $350 million equity raise

  • ALS Ltd has posted robust full-year results for the 2025 financial year, with underlying revenue (EBITDA) up 16% to $3 billion, while launching a $350 million equity raise to expand lab capacity and pursue growth opportunities in its core testing markets. The global testing, inspection and certification (TIC) company delivered full-year underlying earnings before interest and tax (EBIT) of $515 million, up 4.7% year-on-year.